Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion

NCT01557907 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DEVICE: Subcutaneous delivery via Medtronic Quick-Set
DEVICE: Intradermal delivery via the BD Research Catheter Set

Sponsor

Becton, Dickinson and Company